The Globe and Mail reports in its Thursday, July 20, edition that National Bank Financial analyst Zachary Evershed is keeping his "sector perform" call on Neighbourly Pharmacy intact. The Globe's David Leeder writes in the Eye On Equities column that Mr. Evershed gave his share target a 50-cent trim to $20. Analysts on average target the shares at $26.72. The Globe says Mr. Evershed believes Neighbourly Pharmacy's reliance on relief pharmacists likely weighed heavier than originally anticipated during its first quarter of fiscal 2024 based on a reversal in the improvement of open job postings, leading him to lower his margin estimate. Mr. Evershed says in a note: "Our channel checks reveal that Neighbourly's open positions count reversed course early in June, giving up prior improvements in vacancies. Even though the gross number of job openings does include postings that are most likely irrelevant to margin recovery (e.g., delivery drivers, clerks), we believe it is nevertheless directionally indicative of reliance on relief pharmacists at levels higher than we anticipated. As such, we are now forecasting $19.2-million in EBITDA on 10-per-cent margins (was 10.3 per cent) in the quarter."